title: Serum albumin as a stable predictor of prognosis during initial treatment in patients with diffuse large B cell lymphoma.
authors.affiliation: Division of Hematological Malignancies, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, FL, USA.
authors.forename: Jennifer
authors.initials: J
authors.lastname: Eatrides
authors.forename: Zachary
authors.initials: Z
authors.lastname: Thompson
authors.forename: Ji-Hyun
authors.initials: JH
authors.lastname: Lee
authors.forename: Celeste
authors.initials: C
authors.lastname: Bello
authors.forename: Samir
authors.initials: S
authors.lastname: Dalia
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy*; D008297:Male; D017063:Outcome Assessment, Health Care / Q000706:statistics & numerical data; D011237:Predictive Value of Tests; D011241:Prednisone / Q000008:administration & dosage; D011379:Prognosis; D016016:Proportional Hazards Models; D000069283:Rituximab; D012709:Serum Albumin / Q000378:metabolism*; D016019:Survival Analysis; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D012709:Serum Albumin; D000069283:Rituximab; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone